Mergers & Acquisitions

• Charlesbank Capital Partners in its acquisition of ImageQuix Holdings, LLC, a portfolio company of ASG Group which is owned by Alpine Investors. 
• Joink LLC, a DIF CIF II portfolio company owned by DIF Capital Partners, in its purchase of Illinois-based fiber optics business Computer Techniques Inc (CTI).
• Third Wave Recovery Systems (TWRX) in its acquisition of SRX, a leader in pharmaceutical rebate management services for the skilled nursing and long-term care industry.
• ProKidney LP, a leading clinical-stage cellular therapeutics company focused on chronic kidney disease, in its combination with Social Capital Suvretta Holdings Corp. III, a special purpose acquisition company (SPAC), resulting in approximately $597 million in gross cash proceeds and its subsequent listing on the Nasdaq (PROK).
• Charlesbank Capital Partners in a leveraged buyout of Solve Advisors, and the subsequent acquisition by Solve Advisors of Advantage Data Inc.
• Berenson Capital Partners in its leveraged buyout of Interactive Digital Solutions and MedSitter.
• Charlesbank Capital Partners in a leveraged buyout of Healthcare Fraud Shield, a SaaS-based software developer.
• The family office of a leading Wall Street figure in the acquisition of:
  • A national youth sports platform;
  • A regional paving company based in the mid-West;
  • A financial services business; and
  • A controlling minority position in a regional fitness platform.
• XCM Solutions, a cloud-based workflow solutions provider for professional tax and accounting firms, in its $160 million sale to Wolters Kluwer Tax & Accounting North America.
• GCM Grosvenor as a co-investor in several significant leveraged buyouts.
• Legacy.com, a Pamplona Capital-backed technology company in multiple bolt-on acquisitions.
• Motus, Inc. in an innovative leveraged buyout by Thoma Bravo, which combined Motus with Runzheimer Inc. to establish the leading vehicle management and reimbursement platform.
• Laddawn, Inc., a leading manufacturer of plastic bags and films for packing applications with over $145 million in annual net sales, to Berry Global Group, Inc. (NYSE: BERY). 
• Kimberly-Clark Corporation in selling its transdermal, micro-needle drug delivery division (Sofusa) to Sorrento Therapeutics for a total of $310 million (including contingent consideration).
• A syndicate of investors in the simultaneous acquisition of three leading pharmaceutical industry firms.
• Princeton Lightwave, a developer of LiDAR technology, in its sale to Argo AI, an investment vehicle of Ford Motor Company.
• A fundless sponsor in the acquisition of an industry-leading SaaS technology company with global operations.
• KeraNetics, a Winston-Salem-based regenerative medicine business in its merger with Microchips Biotech.
• JN Phillips Auto Glass in a leveraged buyout by CenterOak Partners LLC and subsequent combination with Techna Glass, Inc. to form TruRoad Holdings, Inc., the second largest autoglass repair company in the U.S.
• A founder-run insurance data analytics firm in its acquisition by a Stone Point Capital-backed platform company.
• A leading investment advisory/broker dealer firm in the strategic acquisition of a rival’s advisors and other assets.
• A middle-market private equity fund in the acquisition of a consumer products platform company.
• A national wholesale grocery company on the acquisition of a grocery distribution company’s assets.
• AT Cross Company, a portfolio company of Clarion Capital Partners, in its acquisition of Sheaffer, BIC’s fine writing instrument business.
• A venture-backed technology company on the sale of all of its assets to a strategic investor.
• An early-stage technology company on the merger of its assets and management team with a foreign rival.
• Unizin in the spinout of its Internet 2 assets.
• A Fortune 50 global financial services firm in the acquisition of the assets of a financial services provider.

Financings

• Third Wave Recovery Systems in a growth equity investment from WindRose Health Investors, LLC.
• PleoPharma, an early stage drug development company focused on addiction treatment, in a preferred financing from multiple investors.
• Synnovation Therapeutics, an early stage drug development company, in a preferred financing.
• ArriVent Biopharma in its $150 million Series A financing.
• NexImmune, Inc., a Maryland-based immunotherapy company, in six private financing transactions as well as its February 2021 IPO, which was reported as the first upsized IPO at the top of its price range without a crossover.
• Viela Bio in its spin-out from AstraZeneca’s MedImmune division to establish a stand-alone company for early-stage inflammation and autoimmunity biologics, as well as its $250 million Series A financing, crossover financing round, and IPO.
• A small molecule drug development company in its $100 million Series A financing.
• The family office of a leading Wall Street figure in multiple investments in:
  • Multiple SPAC PIPE financings; and
  • A Major League Baseball team syndicate.
• The family office of a leading Wall Street figure in multiple investments in:
  • A medical device marketing business;
  • A craft liquor producer;
  • A technology-backed restaurant platform;
  • A fast casual concept restaurant platform.
• An early stage biotech venture fund in its formation, incubation of several start up companies, and ultimate fundraising.
• The family office of a leading figure in the biotech industry in over a dozen minority investments in various early-stage biotechnology issuers.
• A medical device company in its $250 million Series D private placement.
• A biotechnology issuer in a $60 million Series C private placement.
• A biotechnology issuer in a $60 million Series D private placement.
• A drug development issuer in a $25 million Series A private placement.
• A drug development issuer in a $15 million Series A private placement.
• A wastewater treatment company on an innovative project financing structure.